cetuximab,afatinib,pembrolizumab,adagrasib
eli lilly,merck,boehringer ingelheim,mirati
['krystal-1', 'mrtx849', 'solid tumor', 'adagrasib']
krystal-1: activity and safety of
adagrasib (mrtx849) in patients with advanced solid tumors harboring a krasg12c mutation #asco23 
Associate Scientific Director, Computational Biology Oncology at @boehringer 🧬 Data Scientist & KRAS, MDM2 , HER2 Research. Tweets are my own.